Pharmafile Logo
Pharmafocus logo
Advanced Search
credit_-_daniel_leal-olivas-afp

Astellas Pharma and Seagen cancer treatment gets MAA acceptance from EMA

March 26, 2021
Medical Communications EMA, oncology

Astellas Pharma and Seagen Inc. have announced that the EMA has accepted their marketing authorisation application (MAA) for enfortumab vedotin, …

News

Novavax delays 100 million vaccines to the EU

March 26, 2021
Medical Communications COVID-19, EU, Vaccine

Novavax is delaying the signing of a contract to supply COVID-19 vaccines to the EU, as the company warned it …

News
Pfizer's New York headquarters

Pfizer begins COVID-19 vaccine testing on young children

March 26, 2021
Medical Communications COVID-19, Pfizer, Vaccine

Pfizer have begun testing its COVID-19 vaccine on children under the age of 12, with the trials’ first participants, a …

News

Starpharma to sell COVID-fighting nose spray in UK

March 25, 2021
COVID-19

Australian biotech company, Starpharma, has announced a deal with LloydsPharmacy to sell its COVID-fighting antiviral nasal spray, Viraleze, in the …

News

Merck and UCLA find new COVID-19 treatment candidate

March 25, 2021
COVID-19, Merck, berzosertib, covid-19 treatment, ucla

Merck (MSD in the UK), the UCLA, and other universities from the US and Germany have uncovered a compound that …

News
AstraZeneca sign

AstraZeneca vaccine found to be 3% less effective after further trial analysis

March 25, 2021
AstraZeneca, AstraZeneca vaccine, COVID-19, COVID-19 vaccine, Vaccine

AstraZeneca have revised their findings from the US study AZD1222 of their COVID-19 vaccine, announcing a 76% efficacy against symptoms …

News

NHS agrees on MSD interim colorectal cancer treatment

March 25, 2021
COVID-19, Cancer, MSD, NHS

MSD has announced a provisional agreement with the NHS to make KEYTRUDA (pembrolizumab) available for eligible patients with metastatic MSI-H/dMMR …

News

AstraZeneca and J&J COVID-19 vaccines face viral vector shortage

March 25, 2021
Astrazenaca, COVID-19, Johnson & Johnson, Vaccine

Both AstraZeneca and J&J face major manufacturing deficiencies for their recombinant vector COVID-19 vaccines, forcing competition over limited production capacity …

News
COVID-19 virus

Pharmafile.com’s weekly COVID-19 news round-up

March 24, 2021
Research and Development COVID-19, covid 19 news, covid-19 news, news roundup

The past week has seen plenty of positive COVID-19 news; the Oxford-AstraZeneca vaccine was deemed safe and effective by the …

News

Roche’s drug cocktail reduces hospitalisation due to COVID-19 in Phase III trial

March 24, 2021
Research and Development COVID-19, Roche, covid-19 treatment

Roche’s antibody drug combination of casirivimab and imdevimab has shown to reduce hospitalisation or death by 70% in non-hospitalised patients …

News

Pfizer and Myovant’s menstrual blood loss treatment reports 78% effectiveness

March 24, 2021
Research and Development Myovant, Pfizer, Phase III trial, fibroids, uterine fibroids

Pfizer and Myovant Science’s relugolix treatment to reduce menstrual blood loss in women with uterine fibroids has shown promising results …

News

Novo Nordisk obesity treatment successful in clinical trials

March 24, 2021
Research and Development Novo Nordisk, obesity

New results from Novo Nordisk’s Phase III study on obesity saw clinically relevant weight loss, without weight regain, in people …

News

Guerbet see positive Phase III results for MRI agent

March 24, 2021
Research and Development MRI

Medical imaging company, Guerbet, have announced the success of its Phase III study into the safety and efficacy of Gadopiclenol, …

News

Zealand’s Zegalogue treatment for hypoglycemia approved by FDA

March 23, 2021
Manufacturing and Production FDA, Zealand Pharma, Zegalogue

The FDA have approved Zealand Pharma’s Zegalogue therapy for the treatment of severe hypoglycemia in patients with diabetes.

News
stock-incyte-01-shutter

Incyte biliary tract cancer treatment approved in Japan

March 23, 2021
Manufacturing and Production EMA, Japan, oncology

The Japanese Ministry of Health, Labour, and Welfare (MHLW) have approved Incyte’s Pemazyre (pemigatinib) for the treatment of patients with …

News
img_4190-e1376666350337-web

Accord Healthcare launches thalidomide for multiple myeloma treatment

March 23, 2021
Manufacturing and Production MHRA, oncology

Accord Healthcare has announced the UK launch of a generic thalidomide, which is used in combination with melphalan and prednisone, …

News
Roche's building

Roche’s Huntington’s disease treatment disappoints in Phase III trial

March 23, 2021
Manufacturing and Production Huntington's, Phase III trial, Roche, huntington's disease, tominersen

Roche has discontinued dosing in a Phase III trial of its tominersen treatment for Huntington’s disease, following discouraging initial data.

News

Novartis prostate cancer treatment sees positive Phase III results

March 23, 2021
Manufacturing and Production Novartis, oncology

Novartis has today announced positive results from its Phase III VISION study with 177Lu-PSMA-617, seeing significant improvements in overall survival …

News

eTheRNA awarded €6.9 million TIGER Grant by European Commission

March 22, 2021
Sales and Marketing Cancer, EU

eTheRNA immunotherapies, a clinical-stage company, has been awarded a grant of €6.9 million by the European Commission to develop a …

News
video_library01

Daiichi Sankyo begins trial for mRNA COVID-19 vaccine in Japan

March 22, 2021
Sales and Marketing COVID-19, Vaccine

Daiichi Sankyo, a global pharmaceutical company that provides services in 20 countries worldwide, has announced the first vaccinations as part …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025